Literature DB >> 19154422

Pharmacological characterization of recombinant NR1/NR2A NMDA receptors with truncated and deleted carboxy termini expressed in Xenopus laevis oocytes.

C A Puddifoot1, P E Chen, R Schoepfer, D J A Wyllie.   

Abstract

BACKGROUND AND
PURPOSE: The carboxy terminal domain (CTD) of NR2 N-methyl-d-aspartate receptor (NMDAR) subunits interacts with numerous scaffolding and signal transduction proteins. Mutations of this region affect trafficking and downstream signalling of NMDARs. This study determines to what extent characteristic pharmacological properties of NR2A-containing NMDARs are influenced by this key functional domain. EXPERIMENTAL APPROACH: Using recombinant receptor expression in Xenopus laevis oocytes and two electrode voltage clamp recordings we characterized pharmacological properties of rat NR1/NR2A NMDARs with altered CTDs. We assessed the effects of truncating [at residue Iso1098; NR2A(trunC)] and deleting [from residue Phe822; NR2A(delC)] the CTD of NR2A NMDAR subunits on agonist potencies, channel block by Mg(2+) and memantine and potentiation of NMDAR-mediated responses by chelating contaminating divalent cations. KEY
RESULTS: Truncation or deletion of the CTD of NR2A NMDAR subunits did not affect glutamate potency [EC(50) = 2.2 micromol.L(-1), NR2A(trunC); 2.7 micromol.L(-1), NR2A(delC) compared with 3.3 micromol.L(-1), NR2A(WT)] but did significantly increase glycine potency [EC(50) = 500 nmol.L(-1), NR2A(trunC); 900 nmol.L(-1), NR2A(delC) compared with 1.3 micromol.L(-1), NR2A(WT)]. Voltage-dependent Mg(2+) block of NR2A(WT)- and NR2A(trunC)-containing NMDARs was similar but low concentrations of Mg(2+) (1 micromol.L(-1)) potentiated NR1/NR2A(delC) NMDARs. Memantine block was not affected by changes to the structure of the NR2A CTD. EDTA-induced potentiation was similar at each of the three NMDAR constructs. CONCLUSIONS AND IMPLICATIONS: Of the parameters studied only minor influences of the CTD were observed; these are unlikely to compromise interpretation of studies that make use of CTD-mutated recombinant receptors or transgenic mice in investigations of the role of the CTD in NMDAR signalling.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19154422      PMCID: PMC2697674          DOI: 10.1111/j.1476-5381.2008.00040.x

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  46 in total

1.  C-Terminal truncation of NR2A subunits impairs synaptic but not extrasynaptic localization of NMDA receptors.

Authors:  F Steigerwald; T W Schulz; L T Schenker; M B Kennedy; P H Seeburg; G Köhr
Journal:  J Neurosci       Date:  2000-06-15       Impact factor: 6.167

Review 2.  NMDA receptor subunits: diversity, development and disease.

Authors:  S Cull-Candy; S Brickley; M Farrant
Journal:  Curr Opin Neurobiol       Date:  2001-06       Impact factor: 6.627

3.  NMDA receptor 2 (NR2) C-terminal control of NR open probability regulates synaptic transmission and plasticity at a cerebellar synapse.

Authors:  Paola Rossi; Elisabetta Sola; Vanni Taglietti; Thilo Borchardt; Frank Steigerwald; Jo Kristian Utvik; Ole Petter Ottersen; Georg Köhr; Egidio D'Angelo
Journal:  J Neurosci       Date:  2002-11-15       Impact factor: 6.167

4.  PSD-95 eliminates Src-induced potentiation of NR1/NR2A-subtype NMDA receptor channels and reduces high-affinity zinc inhibition.

Authors:  Yasue Yamada; Takashi Iwamoto; Yoshifumi Watanabe; Kenji Sobue; Makoto Inui
Journal:  J Neurochem       Date:  2002-05       Impact factor: 5.372

5.  Export from the endoplasmic reticulum of assembled N-methyl-d-aspartic acid receptors is controlled by a motif in the c terminus of the NR2 subunit.

Authors:  Lynda M Hawkins; Kate Prybylowski; Kai Chang; Caroline Moussan; F Anne Stephenson; Robert J Wenthold
Journal:  J Biol Chem       Date:  2004-04-21       Impact factor: 5.157

6.  Neuropathic sensitization of behavioral reflexes and spinal NMDA receptor/CaM kinase II interactions are disrupted in PSD-95 mutant mice.

Authors:  Emer M Garry; Andrew Moss; Ada Delaney; Francis O'Neill; James Blakemore; Julian Bowen; Holger Husi; Rory Mitchell; Seth G N Grant; Susan M Fleetwood-Walker
Journal:  Curr Biol       Date:  2003-02-18       Impact factor: 10.834

7.  Modulation by magnesium of the affinity of NMDA receptors for glycine in murine hippocampal neurones.

Authors:  L Y Wang; J F MacDonald
Journal:  J Physiol       Date:  1995-07-01       Impact factor: 5.182

8.  Differential modulation of NR1-NR2A and NR1-NR2B subtypes of NMDA receptor by PDZ domain-containing proteins.

Authors:  Takashi Iwamoto; Yasue Yamada; Kei Hori; Yoshifumi Watanabe; Kenji Sobue; Makoto Inui
Journal:  J Neurochem       Date:  2004-04       Impact factor: 5.372

9.  Further characterization of the molecular interaction between PSD-95 and NMDA receptors: the effect of the NR1 splice variant and evidence for modulation of channel gating.

Authors:  A Richard Rutter; Fiona M Freeman; F Anne Stephenson
Journal:  J Neurochem       Date:  2002-06       Impact factor: 5.372

10.  Protein kinase C activation modulates alpha-calmodulin kinase II binding to NR2A subunit of N-methyl-D-aspartate receptor complex.

Authors:  F Gardoni; C Bellone; F Cattabeni; M Di Luca
Journal:  J Biol Chem       Date:  2000-12-04       Impact factor: 5.157

View more
  6 in total

1.  The NMDA receptor intracellular C-terminal domains reciprocally interact with allosteric modulators.

Authors:  Kiran Sapkota; Kim Dore; Kang Tang; Mark Irvine; Guangyu Fang; Erica S Burnell; Roberto Malinow; David E Jane; Daniel T Monaghan
Journal:  Biochem Pharmacol       Date:  2018-11-29       Impact factor: 5.858

2.  Controlling NMDA receptor subunit composition using ectopic retention signals.

Authors:  David Stroebel; Stéphanie Carvalho; Teddy Grand; Shujia Zhu; Pierre Paoletti
Journal:  J Neurosci       Date:  2014-12-10       Impact factor: 6.167

Review 3.  Structure, Function, and Pharmacology of Glutamate Receptor Ion Channels.

Authors:  Kasper B Hansen; Lonnie P Wollmuth; Derek Bowie; Hiro Furukawa; Frank S Menniti; Alexander I Sobolevsky; Geoffrey T Swanson; Sharon A Swanger; Ingo H Greger; Terunaga Nakagawa; Chris J McBain; Vasanthi Jayaraman; Chian-Ming Low; Mark L Dell'Acqua; Jeffrey S Diamond; Chad R Camp; Riley E Perszyk; Hongjie Yuan; Stephen F Traynelis
Journal:  Pharmacol Rev       Date:  2021-10       Impact factor: 18.923

4.  A eukaryotic specific transmembrane segment is required for tetramerization in AMPA receptors.

Authors:  Catherine L Salussolia; Quan Gan; Rashek Kazi; Puja Singh; Janet Allopenna; Hiro Furukawa; Lonnie P Wollmuth
Journal:  J Neurosci       Date:  2013-06-05       Impact factor: 6.167

5.  Amino terminal domains of the NMDA receptor are organized as local heterodimers.

Authors:  Chia-Hsueh Lee; Eric Gouaux
Journal:  PLoS One       Date:  2011-04-22       Impact factor: 3.240

6.  Common synaptic phenotypes arising from diverse mutations in the human NMDA receptor subunit GluN2A.

Authors:  Marwa Elmasri; Daniel William Hunter; Giles Winchester; Ella Emine Bates; Wajeeha Aziz; Does Moolenaar Van Der Does; Eirini Karachaliou; Kenji Sakimura; Andrew Charles Penn
Journal:  Commun Biol       Date:  2022-02-28
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.